KARIN NEWELL: Open Payments
NPI 1114917788 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 6 payments from 6 companies in 2025. Trend: 2023 $67 · 2024 $114 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: JARDIANCE, Attruby, Repatha, Wegovy, LEQVIO, ELIQUIS.
Industry payments across MN — which companies pay providers there.
